Mar 22, 2023
Drs John M. Kane and Jose Rubio-Lorente discuss the value of long-acting injectable formulations in reducing the risk for relapse and rehospitalization for patients diagnosed with schizophrenia.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984482). The...
Mar 22, 2023
Drs John M. Kane and Jonathan Meyer discuss treatment-resistant schizophrenia, how common it is, how to detect and manage it, and how delays in the initiation of treatment negatively affect patients.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984480)....